48. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019Am J Clin Nutr 2001; 74: 833-9.
49. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019).Eur J Clin Nutr. 2000 Mar;54(3):263-7.
50. Meydani SN, Ha WK. Immunologic effects of yogurt.Am J Clin Nutr. 2000 Apr;71(4):861-72.
51. Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001.J Am Coll Nutr. 2001 Apr;20(2 Suppl):149-56.
52. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.BMJ. 2001 Jun 2;322(7298):1327. Texte intégral : http://bmj.bmjjournals.com
53. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety.Am J Clin Nutr. 2004 Feb;79(2):261-7.
54. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria.Pediatr Allergy Immunol. 2004 Apr;15(2):152-8.
55. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.Am J Gastroenterol. 2000 May;95(5):1231-8.
56. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1143-7.
57. Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.Dig Dis Sci. 2002 Nov;47(11):2615-20.
58. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.Aliment Pharmacol Ther. 2003 Apr 1;17(7):895-904.
59. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.Am J Gastroenterol. 1996 Aug;91(:1579-85.
60. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005 Mar;128(3):541-51.
61. Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents. 2003 Oct;22(4):360-6. Review.
62, Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004 Sep;80(3):737-41.
63. Linsalata M, Russo F, Berloco P et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter. 2004 Apr;9(2):165-72.
64. Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003 Sep;19(9):716-21.
65. Madden JA, Plummer SF, Tang J et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005 Jun;5(6):1091-7.
66. Plummer SF, Garaiova I, Sarvotham T et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005 Jul;26(1):69-74.
67. Nista EC, Candelli M, Cremonini F et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1181-8.
68. Myllyluoma E, Veijola L, Ahlroos T et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther. 2005 May 15;21(10):1263-72.
69. Sykora J, Valeckova K, Amlerova J et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol. 2005 Sep;39(:692-8.
70. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema.Clin Exp Allergy. 2000 Nov;30(11):1604-10.
71. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis.J Allergy Clin Immunol. 2003 Feb;111(2):389-95.
72. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability.J Pediatr Gastroenterol Nutr. 2003 Feb;36(2):223-7.
73. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy.J Allergy Clin Immunol. 1997 Feb;99(2):179-85.
74. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005 Sep;90(9):892-7.
75. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001 Feb;73(2 Suppl):430S-436S. Review. Texte intégral : http://www.ajcn.org
76. Marteau PR. Probiotics in clinical conditions. Clin Rev Allergy Immunol. 2002 Jun;22(3):255-73. Review.
77. Jeavons HS. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus. J Obstet Gynecol Neonatal Nurs. 2003 May-Jun;32(3):287-96. Review. Texte intégral : http://jogn.awhonn.org
78. Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial.BMJ. 2004 Sep 4;329(7465):548. Epub 2004 Aug 27. Texte intégral : http://bmj.bmjjournals.com
79. de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000 Feb;71(2):405-11. Review. Texte intégral : http://www.ajcn.org
80. Hlivak P, Odraska J, Ferencik M et al. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl Lek Listy. 2005;106(2):67-72.
81. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int. 1992;49(3):125-9.
82. Aso Y, Akaza H, Kotake T et al. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol. 1995;27(2):104-9.
83. Weber G, Adamczyk A, Freytag S. [Treatment of acne with a yeast preparation]. [Article en allemand, résumé en anglais]. Fortschr Med. 1989 Sep 10;107(26):563-6.
84. Barbut Frédéric. Managing antibiotic associated diarrhoea. Editorials. BMJ 2002;324:1345-1346 ( 8 June ) http://bmj.bmjjournals.com